DuPont plans to split into three companies and CEO Breen will step down
DuPont plans to split into three listed companies to join a group of industrial enterprise groups seeking to increase returns by segmenting smaller and more focused businesses. The company announced on Wednesday that it will split its electronics and water business through a duty-free transaction, and the remaining business will focus on industries such as biopharmaceuticals and medical devices, with products including Tyvek and Kevlar. Prior to that, a series of benchmark companies such as Johnson & Johnson, United Technologies, Danaher, and General Electric have all been spin-off in recent years to create more value for shareholders. CEO Ed B says DuPont
Express News | NYSE Order Imbalance 138609.0 Shares on Buy Side
Expert Ratings For Johnson & Johnson
Johnson & Johnson (NYSE:JNJ) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.The table below offers a condensed view of their recent r
Express News | 'Disease Experts Predict A Small Rise In Covid-19 Cases This Summer' - CNBC
Express News | RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $175 Price Target
Johnson & Johnson Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/22/2024 15.21% RBC Capital → $175 Reiterates Outperform → Outperform 05/16/2024 15.21% RBC Capital → $1
Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship
Nanobiotix (NBTX) said Tuesday it has aligned with Johnson & Johnson's (JNJ) Janssen Pharmaceutica at their Joint Strategy Committee to transfer the global sponsorship of the phase 3 head and neck can
Shockwave Medical Gains After HSR Waiting Period for Sale to J&J Expires
Express News | Shockwave Medical Inc: Expiration of Waiting Period Under Hsr Act Satisfies One of Conditions to Closing of Merger
Express News | Shockwave Medical: Required Waiting Period Under Hsr Act With Respect to Merger With Johnson & Johnson Expired at 11:59 P.m., Eastern Time on May 20
Express News | NYSE Order Imbalance 283783.0 Shares on Buy Side
Smart Money Is Betting Big In JNJ Options
Deep-pocketed investors have adopted a bullish approach towards Johnson & Johnson (NYSE:JNJ), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unv
How to Maximize Your Retirement Portfolio With These Top-Ranked Dividend Stocks
Express News | J&J: Results Showed Superiority of Both Subcutaneous Maintenance Doses Versus Placebo and Ustekinumab
Express News | Tremfya® (Guselkumab) Demonstrates Superiority Versus Stelara® (Ustekinumab) in Phase 3 Crohn's Disease Program
Teva, Alvotech Launch Biosimilar Against AbbVie's Humira
Express News | J&J: Tremfya (Guselkumab) Demonstrates Superiority Vs Stelara (Ustekinumab) in Phase 3 Crohn’s Disease Program
Express News | J&J: In Results Versus Ustekinumab Both Doses of Tremfya Showed Statistically Significant Differences on All Prespecified Pooled Endoscopic Endpoints
Express News | J&J: Data Showed Both Maintenance Doses of Tremfya Met Composite Co-Primary Endpoints Compared to Placebo in Each Individual Study
J&J-backed Rapport Therapeutics Files for $100M IPO
No Data